Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Google Inc (GOOG) vs Hims and Hers Health Inc (HIMS) Price & Performance

Google IncTrade
Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

Google Inc vs Hims and Hers Health Inc — how do they compare? Google Inc trades at $370.76 (market cap $4.52T), while Hims and Hers Health Inc trades at $34.34 (market cap $8.60B). The key difference: Google Inc is far larger — about 525.6× Hims and Hers Health Inc's market cap, and Google Inc pays a 0.24% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.

GOOGHIMS
Market Cap
$4.52T$8.60B
Volume
1,511,127
Sector
TechnologyHealth
52-Week High
$399.06$66.18
52-Week Low
$183.77$14.52
Enterprise Value
$4.49T$8.98B
Dividend Yield
0.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Google Inc

Alphabet (GOOG) trades at $370.43, up 3.67% on the day, with strong bullish momentum from recent earnings beats and a consensus analyst price target of $457.50. The stock shows robust fundamentals with 2025 revenue of $402.84B, net income margin of 37.92%, and consistent cash flow growth. Technical indicators are bullish, with the current price near resistance at $374, while sentiment is positive due to Warren Buffett's recent endorsement and AI-driven growth prospects.

Outlook remains favorable with earnings growth and AI expansion as key catalysts, though regulatory risks and market volatility pose challenges. The stock offers upside potential aligned with analyst targets, supported by high institutional ownership and strong profitability metrics.

Hims and Hers Health Inc

Hims & Hers Health trades at $35.52, up 1.05% today, with a bullish technical signal from moving averages and a consensus analyst price target of $33.57. Recent earnings show volatility with a Q1 2026 miss, but revenue grew to $2.35 billion in 2025. The company benefits from expansion in weight-loss therapies and a $400 million JPMorgan facility, though high valuations like a P/E of 57.14 and negative net income margin pose concerns.

Outlook is mixed: growth opportunities in telehealth and GLP-1 drugs support upside, but earnings inconsistency and regulatory risks from FDA reviews require caution. Analysts are 35% buy-rated, highlighting potential if execution improves, yet investors face volatility near key resistance at $38.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Google Inc

Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.

Read more on GOOG

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS